Data Corporation

Data Sciences International (DSI) is a global leader in the development of wireless implantable telemetry systems and physiological monitoring solutions for preclinical research. The company provides integrated hardware and software platforms that allow researchers to monitor chronic physiological data in freely moving, stress-free laboratory animals. DSI's technology is widely utilized by pharmaceutical companies, contract research organizations, and academic institutions to support drug safety, efficacy, and toxicology studies. Since its acquisition by Harvard Bioscience, DSI continues to innovate in the fields of cardiovascular, respiratory, and central nervous system research.